Haiyong Ye
1PUBLICATIONS
0CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (1)
Sort by Publication Date:
|Jun 11, 2021
Anlotinib, a novel TKI, as a third-line or further-line treatment in patients with advanced non-small cell lung cancer in China: A systemic review and meta-analysis of its efficacy and safety.Haiyong Ye, Zhaoyi Li, Kangning Liu
Pageof 1
